Law 360

JULY 12, 2022

Facing a continuing battle for control of the company after a Delaware vice chancellor disqualified or invalidated most of its current or proposed directors on Friday, gene sequencing venture Genapsys Inc. opened a sale-focused Chapter 11 in Delaware bankruptcy court.

Court 52

Court 52

Law 360

JULY 8, 2022

Gene sequencing venture GenapSys Inc. had most of its current board disqualified and its purposed replacement board invalidated on Friday in Delaware Court of Chancery rulings that also directed the company to hold an annual meeting.

Court 40

Court 40

Law 360

JULY 13, 2022

Bankrupt DNA sequencing technology company GenapSys Inc. received permission on Wednesday from a Delaware court to access $1 million in debtor-in-possession financing that comes with a set of deadlines for approval of a Chapter 11 asset sale.

Finance 40

Finance Technology Court 40

Law 360

JUNE 10, 2022

The former CEO of gene sequencing company GenapSys Inc. lost his bid for more access to the work of the special committee that is considering putting the company into bankruptcy, while the committee got a warning from Delaware Chancery Court to be transparent and "tread carefully going forward."

Court 40

Court 40